BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32411801)

  • 41. Distribution of HPV genotypes in cervical cancer in multi- ethnic Malaysia.
    Hamzi Abdul Raub S; Isa NM; Zailani HA; Omar B; Abdullah MF; Mohd Amin WA; Noor RM; Ayub MC; Abidin Z; Kassim F; Vicknesh V; Zakaria Z; Kamaluddin MA; Tan GC; Syed Husain SN
    Asian Pac J Cancer Prev; 2014; 15(2):651-6. PubMed ID: 24568473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Kamal M; Lameiras S; Deloger M; Morel A; Vacher S; Lecerf C; Dupain C; Jeannot E; Girard E; Baulande S; Dubot C; Kenter G; Jordanova ES; Berns EMJJ; Bataillon G; Popovic M; Rouzier R; Cacheux W; Le Tourneau C; Nicolas A; Servant N; Scholl SM; Bièche I;
    Br J Cancer; 2021 Feb; 124(4):777-785. PubMed ID: 33191407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus and cervical neoplasia.
    Einstein MH; Goldberg GL
    Cancer Invest; 2002; 20(7-8):1080-5. PubMed ID: 12449741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
    Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
    Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma.
    Xu S; Shi C; Zhou R; Han Y; Li N; Qu C; Xia R; Zhang C; Hu Y; Tian Z; Liu S; Wang L; Li J; Zhang Z
    Clin Transl Med; 2024 Jan; 14(1):e1556. PubMed ID: 38279874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic cloning and characterization of the nonoccupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa.
    Bauer-Hofmann R; Borghouts C; Auvinen E; Bourda E; Rösl F; Alonso A
    Virology; 1996 Mar; 217(1):33-41. PubMed ID: 8599218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman.
    Einstein MH; Cruz Y; El-Awady MK; Popescu NC; DiPaolo JA; van Ranst M; Kadish AS; Romney S; Runowicz CD; Burk RD
    Clin Cancer Res; 2002 Feb; 8(2):549-54. PubMed ID: 11839676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients].
    Liu JH; Huang X; Liao GW; Li JD; Li YF; Li MD; Rose B; Thompson C
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):748-52. PubMed ID: 12899750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A research for the relationship between human papillomavirus and human uterine cervical carcinoma. I. The identification of viral genome and subgenomic sequences in biopsies of Chinese patients.
    Si JY; Lee K; Han R; Zhang W; Tan BB; Song GX; Liu S; Chen LF; Zhao WM; Jia LP
    J Cancer Res Clin Oncol; 1991; 117(5):454-9. PubMed ID: 1653781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions.
    Choo KB; Chen CM; Han CP; Cheng WT; Au LC
    J Med Virol; 1996 May; 49(1):15-22. PubMed ID: 8732866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
    Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
    J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
    Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions.
    Das BC; Sharma JK; Gopalakrishna V; Luthra UK
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2327-36. PubMed ID: 1328489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Pinatti LM; Gu W; Wang Y; Elhossiny A; Bhangale AD; Brummel CV; Carey TE; Mills RE; Brenner JC
    Cancer; 2021 Oct; 127(19):3531-3540. PubMed ID: 34160069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women.
    Cañadas MP; Videla S; Darwich L; Tarrats A; Piñol M; García-Cuyás F; Llatjos M; Alcalde C; Fernández I; Sirera G; Clotet B
    J Clin Virol; 2010 Jul; 48(3):198-201. PubMed ID: 20427229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of transcriptionally-active human papillomavirus integrants through nanopore sequencing reveals viable targets for gene therapy against cervical cancer.
    Zhao Q; Yang S; Hao S; Chen Z; Tang L; Wu Z; Wu J; Xu M; Ma Z; Zhou L; Xu J; Qin Q
    J Med Virol; 2024 Jun; 96(6):e29769. PubMed ID: 38932482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
    Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.